The Zollinger-Ellison syndrome is usually caused by a single islet cell tumour in an otherwise normal pancreas. It may also be seen rarely in association with the autosomal dominant syndrome, multiple endocrine neoplasia type I. The Zollinger-Ellison syndrome may also be caused by gastrin secreting primary tumours in the antral or duodenal mucosa, or other sites. ' Approximately two-thirds of solitary gastrin producing islet cell tumours exhibit malignant behaviour, with hepatic metastases being found by arteriography or computed axial tomography (CAT) at the time of diagnosis in about 25% of patients. 2 Gastrin pioducing islet cell tumours may secrete more than one hormone. His symptoms settled but six months later, despite continuing full dose cimetidine, he had a haematemesis and was again found to have multiple small duodenal ulcers. The fasting plasma gastrin concentration was 1100 pmol/l (normal 40 pmol/l), rising paradoxically to 1600 pmol/l 20 minutes after a bolus of intravenous GIH secretin 2 U/kg body weight. Plasma gastrin concentration was measured by radioimmunoassay in Professor S R Bloom's laboratory at Hammersmith Hospital, using antibody GAS 179. Cimetidine was stopped for 12 hours, and a pentagastrin test showed a basal acid output of 35-7 mmol/h with a peak acid output of 51-3 mmol/h.
The Zollinger-Ellison syndrome was diagnosed and the patient was initially treated with ranitidine 150 mg bd. He was considered unfit for major surgery, so localisation of the tumour by portal venous sampling was not attempted. Follow 
